Work

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial

Year: 2021
Type: article
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W4200516072
FWCI: 4.021
Cites: 11
Cited by: 25
Related to: 10